My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

1.330 +0.110 (+9.02%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lucid Diagnostics Inc. - Common Stock

< Previous 1 2 3 Next >

3 Hypergrowth Stocks That Speculators Should Keep Tabs On ↗

July 29, 2024

While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time.

Via InvestorPlace

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 ↗

May 20, 2024

Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments.

Via InvestorPlace

LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024 ↗

May 13, 2024

LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 29, 2024

Via Benzinga

Earnings Preview: Lucid Diagnostics ↗

March 22, 2024

Via Benzinga

Earnings Preview For Lucid Diagnostics ↗

November 10, 2023

Via Benzinga

Where Lucid Diagnostics Stands With Analysts ↗

May 17, 2023

Via Benzinga

Preview: Lucid Diagnostics's Earnings ↗

May 12, 2023

Via Benzinga

3 Penny Stocks That Could Make a Big Comeback by the End of Q2 ↗

April 19, 2024

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.

Via InvestorPlace

LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023 ↗

March 25, 2024

LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 25, 2024 ↗

March 25, 2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 18, 2024

Via Benzinga

Lucid Diagnostics Earnings Perspective: Return On Capital Employed ↗

March 15, 2023

Via Benzinga

A Preview Of Lucid Diagnostics's Earnings ↗

March 13, 2023

Via Benzinga

PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs ↗

January 18, 2023

Via Benzinga

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 24, 2023

Via Benzinga

Why PAVmed Shares Are Falling Today ↗

January 18, 2023

PAVmed Inc. (NASDAQ: PAVM) shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 05, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.

Via Benzinga

How Is The Market Feeling About Lucid Diagnostics Inc. - Common Stock? ↗

March 30, 2022

Lucid Diagnostics Inc. - Common Stock's (NASDAQ:LUCD) short percent of float has fallen 4.35% since its last report. The company recently reported that it has 378.70 thousand...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

March 29, 2022

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 02, 2022

Gainers Syros Pharmaceuticals (NASDAQ:SYRS

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.